Equipoise is an androgenic anabolic steroid created in 1949 which came out for public use in 1970 used as a medication and was then turned into a medication for animals. Equipoise is derived from testosterone. It possesses an undecylenate ester which is only a carbon longer than decanoate. This generates a stable release of the substance into the bloodstream for approximately 28 days. This makes equipoise an easy steroid to use by many athletes because it is not as painful after an injection. What characterises this substance is the length of the cycle which is typically longer in order to obtain a noticeable androgenic effect.
- Additional information
Boldenone Undecylenate (Equipoise)
Boldenone Undecylenate or Equipoise is the modified form of testosterone which possesses a double bond on carbon 1 and 2. This reduces its ability to aromatize estrogens and its anabolic power. It possesses an undecylenic acid bond to the 17-beta hydroxyl group.
Equipoise does not have a high aromatization capacity. When higher doses are used for longer periods of time it may be necessary to use antiestrogens or inhibitors like arimidex. The androgenic effects are not high because its androgenicity is very low. This makes it a very safe substance for women to use. However if higher doses are used there are risk of side effects such as acne and oily skin.
Something particular about equipoise is the raw material, unlike other substances it is an oil base liquid. Its color is generally amber and has a high viscosity which needs to be diluted correctly for an adequate concentration.
Equipoise or Boldenone Undecylenate as a finished product is a yellow colored liquid. The viscosity is in accordance to its concentration. Concentrations are typically low which allows for easy filtration and application.